Regenerative medicine technique brings surgeons one step closer to helping patients
A new study by researchers at Children’s Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.
Published online January 8 by the American Journal of Physiology: GI & Liver, the work brings surgeons one step closer to helping human patients using this regenerative medicine technique.
Tissue-engineered small intestine (TESI) grows from stem cells contained in the intestine and offers a promising treatment for short bowel syndrome (SBS), a major cause of intestinal failure, particularly in premature babies and newborns with congenital intestinal anomalies.  TESI may one day offer a therapeutic alternative to the current standard treatment, which is intestinal transplantation, and could potentially solve its largest challenges – donor shortage and the need for lifelong immunosuppression.
Tracy C. Grikscheit, MD, a principal investigator in The Saban Research Institute of CHLA and its Developmental Biology and Regenerative Medicine program, is also a pediatric surgeon at Children’s Hospital Los Angeles and an assistant professor of surgery at the Keck School of Medicine of the University of Southern California.
Grikscheit aims to help her most vulnerable young patients, including babies who are born prematurely and develop a devastating disease called necrotizing enterocolitis (NEC), where life-threatening intestinal damage requires removal of large portions of the small intestine. Without enough intestinal length, the babies are dependent on intravenous feeding, which is costly and may cause liver damage. Â NEC and other contributors to intestinal failure occur in 24.5 out of 100,000 live births, and the incidence of SBS is increasing. Â Nearly a third of patients die within five years.
CHLA scientists had previously shown that TESI could be generated from human small intestine donor tissue implanted into immunocompromised mice.  However, in those initial studies – published in July 2011 in the biomedical journal Tissue Engineering, Part A – only basic components of the intestine were identified.  For clinical relevance, it remained necessary to more fully investigate intact components of function such as the ability to form a healthy barrier while still absorbing nutrition or specific mechanisms of electrolyte exchange.
The new study determined that mouse TESI is highly similar to the TESI derived from human cells, and that both contain important building blocks such as the stem and progenitor cells that will continue to regenerate the intestine as a living tissue replacement. Â And these cells are found within the engineered tissue in specific locations and in close proximity to other specialized cells that are known to be necessary in healthy human intestine for a fully functioning organ.
Read more: Researchers Grow Functional Tissue-Engineered Intestine from Human Cells
The Latest on: Regenerative medicine
via Google News
The Latest on: Regenerative medicine
- QC Kinetix (Fall River) is a Premier Fall River Regenerative Medicine Clinicon May 18, 2022 at 7:00 am
River, MA - The traditional treatment approaches to chronic conditions often involve invasive procedures, medication, or replacement surgery. While ...
- QC Kinetix (The Woodlands) Offers Regenerative Medicine as a Viable Alternative for Pain Treatment in The Woodlands, TXon May 18, 2022 at 6:15 am
The Woodlands, TX - Chronic pain and injuries are some of the most common health conditions that people face today. With traditional treatment methods often proving to be ineffective and associated ...
- QC Kinetix (Albuquerque-West) Offers Regenerative Medicine as an Alternative Treatment for Chronic Pain and Sports Injurieson May 18, 2022 at 6:11 am
Albuquerque, NM - Regenerative medicine is a non-invasive treatment option that capitalizes on the body's natural abilities to heal, repair, and restore ...
- (26.1% CAGR) Regenerative Medicine Market Size [2021-2026] to Reach USD 151949.5 Millionon May 18, 2022 at 3:10 am
Pune, India, May 18, 2022 (GLOBE NEWSWIRE) -- The global regenerative medicine market is likely to expand considerably in the coming years due to growing applications in the treatment of chronic ...
- ECC Foundation to Promote Development of Blockchain in Regenerative Medicineon May 17, 2022 at 11:13 pm
Lippert, the former executive deputy CEO of its new strategic partner, Metlife, to jointly establish the ECC Foundation. This was done on the grounds of promoting the global development of ...
- Former Mr. Universe Dr. Chris Zaino Reveals How Regenerative Medicine Helps Build Championson May 17, 2022 at 7:54 am
While plenty of hubbub and headlines are made about the annual Miss Universe contest, the public is slightly less acquainted with its men’s bodybuilding counterpart, Mr. Universe, that carries all the ...
- APEX Biologix Launches its Newly Reconfigured Bone Marrow System for Regenerative Medicine Procedureson May 17, 2022 at 7:00 am
XCELL BMC to Provide System Features Specifically Designed for Surgery Settings in Hospitals, Clinics, and Surgical Centers ...
- University Of Colorado To Invest $200 Million In New Regenerative Medicine Instituteon May 12, 2022 at 4:49 am
The University of Colorado Anschutz Medical Campus has announced that it invest $200 million over the next five years to create the Gates Institute, a research and treatment center that will focus on ...
- $83 Bn Regenerative Medicine Markets - Global Opportunity Analysis and Industry Forecast, 2021-2022 & 2030 - ResearchAndMarkets.comon May 11, 2022 at 6:29 am
The “Regenerative Medicine Market by Product Type, Material, Application and End user (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021-2030” ...
- Regenerative Medicine Market: By Key Players, Market Size, Deployment Type, Applications, Vertical, and Forecast: 2022-2031on April 27, 2022 at 8:59 pm
Japan, Japan, Thu, 28 Apr 2022 03:57:48 / Comserve Inc. / -- Global Regenerative Medicine Market was valued at US$ 29.1 billion in 2031 and is anticipated to reach US$ 178.6 billion by 2031 ...
via Bing News